OUR FREE LIVE REAL WORLD MASTERCLASS SERIES WILL BE BACK AFTER THE SUMMER ‘How to ensure success and avoid pitfalls in Real World studies by Understanding Healthcare in Europe and Asia’ Dates: Restarting in September 2023 | Time: 5pm CET | 4pm UK | 11am EST | 8am PST OXON will be resuming the series…
Read more
Thanks for your time at the 38th International Conference on PharmacoEpidemiology, ICPE 2022. August 24-28, 2022 | Bella Center Copenhagen | Copenhagen, Denmark At OXON Epidemiology, we would like to thank you for visiting our booth at ICPE 2022 and contributing to our success during the event. Thanks for your interest in our services during the event…
Read more
Nawab Qizilbash will be speaking at the Global Clinical Trial Connect 2022 Virtual Conference and Expo 21 – 22 September 2022 Nawab Qizilbash, Senior Clinical Epidemiologist and Head of OXON will be participating at the Global Clinical Trials Connect 2022 virtual summit on Wednesday 21 September at 13:25h BST | 14:25 CEST. Under the title…
Read more
OXON’s real-world studies at the 38th International Conference on PharmacoEpidemiology, ICPE 2022. Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community August 24-28, 2022 | Bella Center Copenhagen | Copenhagen, Denmark At OXON we are excited to be supporting ICPE 2022 as an exhibitor, presenting our capabilities and research during this in-person event for scientific and…
Read more
FREE LIVE REAL WORLD MASTERCLASS SERIES 2022-2023 ‘How to ensure success and avoid pitfalls in Real World studies by Understanding Healthcare in Europe and Asia’ Dates: Monthly starting in February 2022 | Time: 5pm CET | 4pm UK | 11am EST | 8am PST OXON is resuming the series of masterclasses on real world evidence…
Read more
OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
The study, published in Lancet Healthy Longevity, suggests that high levels of cholesterol in middle-age are associated with an increased risk of developing dementia and Alzheimer’s disease. The retrospective cohort study ‘Blood cholesterol and risk of dementia in a retrospective cohort of over 1.8 million people over two decades’, presented at the 35th International Conference…
Read more
RWE Masterclass 4: ‘Individualizing Benefit Risk’ Session 4: ‘Individualizing Benefit Risk’, will take place on Wednesday, 16 June 2021 at 5 pm CEST MORE INFORMATION|REGISTER HERE SUMMARY: Conventional methods of benefit-risk overly focus on overall results; subgroups have limitations, and the relative importance of events may not be considered. Individualizing benefit-risk more precisely would…
Read more
RWE Masterclass 3: ‘Non-randomised comparative studies’ Non-randomised comparative studies will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist and statistician, and…
Read more
RWE Live Masterclass 2: ‘The Tyranny of Propensity Scores’ Propensity Scores will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist…
Read more
